| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.6 | 0.03 |